Governor's Conference 2016
THE GOVERNOR'S CONFERENCE
ON EFFECTIVE PARTNERING IN CANCER RESEARCH
The Interface of Clinical and Translational Science
Wolfensohn Hall, Institute for Advanced Study
APRIL 8, 2016
| 8:55 am - 9:00 am |
WELCOMING REMARKS |
| 9:00 am - 10:00 am | William Sellers Novartis Institutes for Biomedical Research The Genetic Basis for Cancer Therapeutics |
| 10:00 am - 11:00 am |
William G. Kaelin, Jr. Dana-Farber Cancer Institute Tackling the Off-Target Problem in Cancer Pharmacology |
| 11:00 am - 11:30 am |
BREAK - Bloomberg Hall Biology Atrium |
| 11:30 am - 12:30 pm | Jeffrey Engelman Massachusetts General Hospital Cancer Center Evolution of Resistance to Targeted Therapies |
| 12:30 pm - 2:00 pm |
LUNCH - Available in Institute Dining Hall |
| 2:00 pm - 3:00 pm |
Ross L. Levine Memorial Sloan Kettering Cancer Center Role of Mutations in Epigenetic Regulators in Pathogenesis of Myeloid Malignancies |
| 3:00 pm - 3:30 pm |
AFTERNOON TEA - Fuld Hall Common Room |
| 3:30 pm - 4:30 pm | David A. Tuveson Cold Spring Harbor Laboratory Organoid Models of Pancreatic Cancer |
| 4:30 pm - 5:30 pm | David T. Ting Massachusetts General Hospital Cancer Center Circulating Tumor Cells: The "Liquid Biopsy" |